SEPTEMBER 2018
Measured by Google Analytics
FEATURED COMPANIES
Pharmaceutical firm seeks to appeal NHS ruling
15 Oct 2018
NORTHERN ECHO UK
1
Dr Reddy’s Labs recalls 35,000 tubes of skin infection cream from US
14 Oct 2018
LIVEMINT
2
Shire opens $1B plant to make rare disease drugs
Eric Palmer
13 Oct 2018
FIERCE PHARMA
3
Seeking cash to fund PhIII for once-failed drug, Adynxx rides to Nasdaq
Amber Tong
13 Oct 2018
ENDPTS
4
Trump administration may require drugmakers to advertise drug prices: report
Angelica LaVito
13 Oct 2018
CNBC
5
Noramco announces provisional patent application of proprietary cannabidiol
13 Oct 2018
MANUFACTURING CHEMIST
6
BMS` Opdivo Flounders in Phase III Trial for Small Cell Lung Cancer
Alex Keown
13 Oct 2018
BIOSPACE
7
U.S. appeals court upholds ruling that canceled Teva Copaxone patents
Jan Wolfe
13 Oct 2018
REUTERS
8
Merck, Samsung Bioepis end development on copy of Sanofi`s Lantus
Andrew Dunn
13 Oct 2018
BIOPHARMA DIVE
9
Natco`s partner Mylan prevails over Teva in Copaxone patent litigation
Viswanath Pilla
13 Oct 2018
MONEY CONTROL
10
MARKET PLACE
Hemin Chloride API needed in Australia
15 Oct 2018
Sodium Saccharin API needed in Iraq
15 Oct 2018
Meropenem (5kg) API needed in Bangladesh
15 Oct 2018
Clemastine Fumarate (15kg) API needed in Spain
15 Oct 2018
Lurasidone API needed in Saudi Arabia
15 Oct 2018
Voxilaprevir (100kg) API needed in Pakistan
15 Oct 2018
Looking for anticancer formulations in India
12 Oct 2018
Ibandronate finished formulation needed in Peru
10 Oct 2018
Ibandronate finished formulation needed in Peru
10 Oct 2018
API registration agent needed in India
04 Oct 2018
Looking for a European pharma CMO
22 Sep 2018
Hydroxy Ethyl Cellulose needed in Iran
15 Oct 2018
Dipropylene Glycol needed in Bangladesh
27 Sep 2018
24 Sep 2018
Kolliwax (300kg) needed in Jordan
18 Sep 2018
Ludipress needed for the US market
14 Sep 2018
Hydroxyethyl Cellulose needed in Uganda
13 Sep 2018
BLOG & ANALYSIS
The big news from the world of pharmaceuticals this week came from two cancer researchers — Ja...
In case you thought the US Food and Drug Administration (FDA) and EU’s actions against China&r...
This week, Phispers brings you new twists to the valsartan impurities saga. First, the FDA posted i...
